Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

ClinicalTrials.gov ID: NCT02651714

Public ClinicalTrials.gov record NCT02651714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 5:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.

Study identification

NCT ID
NCT02651714
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
168 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2016 (Actual)
Primary completion
Aug 4, 2017 (Actual)
Completion
Aug 4, 2017 (Actual)
Last update posted
Jun 13, 2024

2016 – 2017

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Vanda Investigational Site Encinitas California 92024 —
Vanda Investigational Site Encino California 91436 —
Vanda Investigational Site Lomita California 90717 —
Vanda Investigational Site San Diego California 92122 —
Vanda Investigational Site San Diego California 92123 —
Vanda Investigational Site Miami Florida 33126 —
Vanda Investigational Site Miami Florida 33136 —
Vanda Investigational Site Ormond Beach Florida 32174 —
Vanda Investigational Site Columbus Georgia 31904 —
Vanda Investigational Site Plainfield Indiana 46168 —
Vanda Investigational Site Crowley Louisiana 70526 —
Vanda Investigational Site St Louis Missouri 63110 —
Vanda Investigational Site Las Vegas Nevada 89119 —
Vanda Investigational Site New York New York 10022 —
Vanda Investigational Site New York New York 10075 —
Vanda Investigational Site High Point North Carolina 27262 —
Vanda Investigational Site Wilmington North Carolina 28405 —
Vanda Investigational Site Winston-Salem North Carolina 27104 —
Vanda Investigational Site Portland Oregon 97239 —
Vanda Investigational Site Philadelphia Pennsylvania 19104 —
Vanda Investigational Site Johnston Rhode Island 02919 —
Vanda Investigational Site Charleston South Carolina 29407 —
Vanda Investigational Site Houston Texas 77030 —
Vanda Investigational Site Pflugerville Texas 78660 —
Vanda Investigational Site San Antonio Texas 78218 —
Vanda Investigational Site West Jordan Utah 84088 —
Vanda Investigational Site Seattle Washington 98101 —
Vanda Investigational Site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02651714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2024 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02651714 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →